Trends in multidrug-resistant tuberculosis: [review]
J. venom. anim. toxins incl. trop. dis
;
14(2): 203-223, 2008.
Article
Dans Anglais
| LILACS, SES-SP, SESSP-ILSLPROD, SES-SP, SESSP-ILSLACERVO, SES-SP
| ID: lil-484561
ABSTRACT
Multidrug-resistant tuberculosis (MDR-TB) is an increasing global problem. The extent and burden of MDR-TB varies significantly from country to country and region to region. Globally, about three per cent of all newly diagnosed patients have MDR-TB and the proportion is higher in patients who had previously received anti-tuberculosis (anti-TB) treatment reflecting the failure of programs designed to ensure complete cure of patients with tuberculosis. The management of MDR-TB is a challenge that should be undertaken by experienced clinicians at centers equipped with reliable laboratory services and implementation of DOTS-Plus strategy.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Tuberculose
/
Tuberculose multirésistante
/
Gènes MDR
/
Mycobacterium tuberculosis
Limites du sujet:
Humains
langue:
Anglais
Texte intégral:
J. venom. anim. toxins incl. trop. dis
Année:
2008
Type:
Article
Institution/Pays d'affiliation:
Secretaria de Estado da Saúde/BR
/
São Paulo State University/BR
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS